entremed inc
EntreMed Files New Clinical Trial With CFDA For ENMD-2076
EntreMed, Inc. has submitted a new clinical trial application with the CFDA for its proprietary oncology drug candidate, ENMD-2076.
EntreMed Inc. Initiates Plans For China Office
EntreMed, Inc., has initiated plans to establish an office in China to facilitate the company’s drug development and clinical trials in that country.